Stocks and Investing Stocks and Investing
Wed, September 13, 2023

Joseph Pantginis Reiterated (APRE) at Strong Buy and Held Target at $20 on, Sep 13th, 2023


Published on 2024-10-28 06:23:21 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Reiterated "Aprea Therapeutics, Inc." (APRE) at Strong Buy and Held Target at $20 on, Sep 13th, 2023.

Joseph, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com